Seasonal influenza vaccine development and mass production may lead to future efforts targeted at developing and evaluating vaccine strategies for Covid-19, say researchers.

In the study, published in the Journal of the American College of Cardiology, the research team evaluated whether existing flu trial networks could offer primary and secondary prevention strategies for patients with cardiovascular disease at risk of complications from Covid-19.